» Articles » PMID: 36551814

Antioxidant Intervention Against Male Infertility: Time to Design Novel Strategies

Overview
Journal Biomedicines
Date 2022 Dec 23
PMID 36551814
Authors
Affiliations
Soon will be listed here.
Abstract

Infertility is a highly prevalent condition, affecting 9-20% of couples worldwide. Among the identifiable causes, the male factor stands out in about half of infertile couples, representing a growing problem. Accordingly, there has been a decline in both global fertility rates and sperm counts in recent years. Remarkably, nearly 80% of cases of male infertility (MI) have no clinically identifiable aetiology. Among the mechanisms likely plausible to account for idiopathic cases, oxidative stress (OS) has currently been increasingly recognized as a key factor in MI, through phenomena such as mitochondrial dysfunction, lipid peroxidation, DNA damage and fragmentation and finally, sperm apoptosis. In addition, elevated reactive oxygen species (ROS) levels in semen are associated with worse reproductive outcomes. However, despite an increasing understanding on the role of OS in the pathophysiology of MI, therapeutic interventions based on antioxidants have not yet provided a consistent benefit for MI, and there is currently no clear consensus on the optimal antioxidant constituents or regimen. Therefore, there is currently no applicable antioxidant treatment against this problem. This review presents an approach aimed at designing an antioxidant strategy based on the particular biological properties of sperm and their relationships with OS.

Citing Articles

Letrozole and Crocin: Protecting Leydig Cells and Modulating Androgen Receptor and CYP19 Gene Expression in Busulfan-Induced Azoospermia.

Nokhbeh Zaeem S, Heydari Nasrabadi M, Salehipour M, Ehtesham S Animals (Basel). 2025; 15(5).

PMID: 40075978 PMC: 11898426. DOI: 10.3390/ani15050697.


Riluzole Reverses Blood-Testis Barrier Loss to Rescue Chemotherapy-Induced Male Infertility by Binding to TRPC.

Huang R, Xia H, Lin W, Wang Z, Li L, Deng J Cells. 2024; 13(23).

PMID: 39682764 PMC: 11640501. DOI: 10.3390/cells13232016.


Empirical Treatments for Male Infertility: A Focus on Lifestyle Modifications and Medicines.

Kaltsas A, Zachariou A, Dimitriadis F, Chrisofos M, Sofikitis N Diseases. 2024; 12(9).

PMID: 39329878 PMC: 11431325. DOI: 10.3390/diseases12090209.


Two-Generation Toxicity Study of the Antioxidant Compound Propyl-Propane Thiosulfonate (PTSO).

Cascajosa-Lira A, Guzman-Guillen R, Pichardo S, Banos A, de la Torre J, Ayala-Soldado N Antioxidants (Basel). 2024; 13(3).

PMID: 38539883 PMC: 10968083. DOI: 10.3390/antiox13030350.


Correlation of Dietary Macro- and Micro-Mineral Intake with Seminal Plasma Quality/Quantity and Oxidant/Antioxidant Status in Infertile Compared to the Normal Men: a Case-Control Study.

Chiti H, Hosseini E, Ebrahimi V, Mousavi S Biol Trace Elem Res. 2023; 202(5):1991-1997.

PMID: 37721681 DOI: 10.1007/s12011-023-03834-6.


References
1.
Menezo Y, Entezami F, Lichtblau I, Belloc S, Cohen M, Dale B . Oxidative stress and fertility: incorrect assumptions and ineffective solutions?. Zygote. 2012; 22(1):80-90. DOI: 10.1017/S0967199412000263. View

2.
Shahidi F, Ambigaipalan P . Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Annu Rev Food Sci Technol. 2018; 9:345-381. DOI: 10.1146/annurev-food-111317-095850. View

3.
Chen Z, Zhong C . Oxidative stress in Alzheimer's disease. Neurosci Bull. 2014; 30(2):271-81. PMC: 5562667. DOI: 10.1007/s12264-013-1423-y. View

4.
Boivin J, Bunting L, Collins J, Nygren K . International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007; 22(6):1506-12. DOI: 10.1093/humrep/dem046. View

5.
Waseem M, Tabassum H, Parvez S . Neuroprotective effects of melatonin as evidenced by abrogation of oxaliplatin induced behavioral alterations, mitochondrial dysfunction and neurotoxicity in rat brain. Mitochondrion. 2016; 30:168-76. DOI: 10.1016/j.mito.2016.08.001. View